Genesis HealthCare Announces Strategic Restructuring Steps to Strengthen Balance Sheet and Chart Path for Recovery

NEXT STORY
Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
PREV STORY
Coastline’s Acquired Brain Injury (ABI) Program is partnering with Brain Strategies & Technology (BEST) and Global Brain Injury Awareness (GBIA) to Celebrate Brain Injury Awareness Month
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020

author_avatar
NASDAQ Market News

Sarepta Therapeutics Announces Plan to Submit a New Drug Application (NDA) for Accelerated Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53

-- The Company met with the FDA Division of Neurology Products in February to ...

author_avatar
NASDAQ Market News

BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017

MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its ...

author_avatar
NASDAQ Market News